Filter By Industry
Select One Biotech Research
Filter By Tag
Select One ACC1 ACC2 Acetylation Acetyltransferase Assay Kit Assay Kits Bps Brd Bromodomain Cancer Cholesterol Drug Discovery Epigenetics EZH Hat Hcv Hdac Hep C JQ1 Methyl Reader Methyltransferase Notch Nsd Parp PBEF PCSK9 PD-1 PD1 Pharmaceutical PHGDH Proteases Rar TNKS Weaver Syndrome Wnt
BPS Bioscience, Inc. Press releases1 - 10 of 12 Press Releases
Apr 23, 2014
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors
Oct 31, 2013
Unique Portfolio of Proteins and Assay Kits for PD-1-related Research and Drug Discovery
Oct 14, 2013
BPS Bioscience, Inc. (“BPS”) announces the addition of a panel of 6 protease enzymes for identifying small molecule inhibitors of the Hepatitis C virus (HCV). These unique enzymes are also available for custom screening and profiling services.
Sep 16, 2013
Expanding the Largest Portfolio of Proteins and Assay Kits for Epigenetic Research and Drug Discovery
Jul 15, 2013
First commercially available NSD kits for inhibitor screening and profiling applications
May 14, 2013
Expanding the Array of Tools Available for Life Science Research
Mar 28, 2013
Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug...
Mar 13, 2013
BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs).
Feb 19, 2013
The Largest Selection of PARP Screening and Profiling Services now available: PARP’s 1, 2, 3, 5A (TNKS1), 5B (TNKS2), 6, 7, 8, 10, 11, 12 and 15.
Jan 28, 2013
Cell Lines now Available for Studying the Retinoic Acid Receptor (RAR), Notch, and Wnt Signaling Pathways
RSS Feed for BPS Bioscience, Inc. Press Releases